Softer Earnings Could Be A Game Changer For Ingredion Stock (INGR)

• Ingredion reported third quarter 2026 sales of US$1,792 million and net income of US$142 million, with earnings per share from continuing operations lower than the same period a year earlier.
• The nine month figures showed broadly similar sales of US$5,434 million but meaningfully lower net income and earnings per share, which highlights pressure on Ingredion’s profitability despite relatively stable top line performance.
• We now consider how Ingredion's softer year to date earnings shape the existing investment narrative around mix shift and margins.

Compare how Ingredion’s softer earnings stack up across the sector by reviewing its profile alongside a curated 35 high quality undervalued stocks that also highlights resilient cash generation and balance sheet strength.

Ingredion Investment Narrative Recap

To back Ingredion as a shareholder, you need to believe the shift toward higher margin Texture & Healthful Solutions and health focused ingredients can offset pressure in more commoditised sweeteners and starches. The latest quarter shows softer earnings on largely steady sales, which keeps the spotlight firmly on execution rather than on a collapse in demand.

Right now, the key short term catalyst is progress on portfolio mix and cost control after prior operational issues at sites like Argo and sourcing pressure in areas such as tapioca. The biggest risk is that input costs, FX swings in Latin America and pricing pass through keep compressing margins. The new results reinforce that risk but do not radically change it.

With earnings under pressure in the first nine months of 2026, the most relevant backdrop is Ingredion's ongoing push to grow Texture & Healthful Solutions and other specialty ingredients. That segment previously delivered strong operating margins, so the thesis leans heavily on management keeping that engine running while the broader starch and sweetener book absorbs pricing and volume friction.

The Tate & Lyle transaction is expected to create a roughly US$10b ingredient solutions group with about US$1.8b of adjusted EBITDA at an 18.1% margin before any cost savings. This sits directly in this context. Integration quality, capital discipline and the speed at which combined operations stabilise earnings now look more important, given the latest quarter confirms how sensitive Ingredion's profitability remains to cost shocks and regional volatility.

Ingredion's narrative projects US$7.6b revenue and US$777.7 million earnings by 2029, based on analyst expectations of 1.8% yearly revenue growth and an earnings increase of about US$185.7 million from US$592.0 million today.

Uncover why Ingredion's fair value indicates a 25% potential upside to its current price, which could narrow quickly.

Exploring Other Perspectives

One alternate angle around Ingredion focuses on earnings quality rather than mix shift. The most pessimistic analysts already saw slower progress, with revenue projected at about US$7.5b and earnings of roughly US$767.9 million by 2029. Those forecasts came before this earnings release, so views across the analyst range may potentially move.

Explore 3 other Ingredion fair value estimates, including one that suggests there could be as much as 9% downside from the current price.

Decide For Yourself

Don't just follow the ticker; dig into the data and build a conviction that's truly your own.

• A great starting point for your Ingredion research is our analysis highlighting 5 key rewards that could impact your investment decision.
• See our latest analysis for Ingredion. The report includes a comprehensive fundamental analysis summarized in a single visual, the Snowflake, making it easy to evaluate Ingredion's overall financial health at a glance.

Looking For More Ideas Beyond Ingredion?

If Ingredion's latest results have you rethinking your watchlist, it can help to line it up against other businesses with different strengths. Use the Simply Wall St Screener to compare this stock to peers with stronger balance sheets, different risk profiles, or higher income potential.

• For investors who care most about capital strength and fundamental resilience, start with a list of solid balance sheet and fundamentals (24 results) that can sit alongside Ingredion in a more defensively built portfolio.
• If downside protection is front of mind, scan a 31 resilient stocks with low risk scores that filters for businesses with more stable risk scores and potentially smoother return profiles.
• For those hunting for less crowded ideas with solid financials, broaden your research with a 19 high quality undiscovered gems that may complement or substitute positions like Ingredion.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com